In some countries, this medicine may only be approved for veterinary use.
ATC (Anatomical Therapeutic Chemical Classification)
CAS registry number (Chemical Abstracts Service)
Inhibitor of 3β-hydroxysteroid dehydrogenase
Inhibitor of the adrenocortical corticosteroid synthesis
Androst-2-ene-2-carbonitrile, 4,5-epoxy-3,17-dihydroxy-, (4α,5α,17β)-
- Trilostanum (Latin)
- Trilostan (German)
- Trilostane (French)
- Trilostano (Spanish)
- Trilostane (OS: DCF, USAN, BAN, JAN)
- Win 24540 (IS: Winthrop)
Mochida Pharmaceutical, Japan
- Vetoryl (veterinary use)
Albrecht, Germany; Dechra, Austria; Dechra, Finland; Dechra, Ireland; Dechra, Netherlands; Dechra, Norway; Dechra, Poland; Dechra, Sweden; Dechra, United States; Dechra Veterinary Products, Belgium; Dechra Veterinary Products, France; Dechra Veterinary Products, United Kingdom; Dermcare-Vet, Australia; MSD Animal Health, Switzerland; RxVet, New Zealand; Selecta, Germany
|BAN||British Approved Name|
|DCF||Dénomination Commune Française|
|JAN||Japanese Accepted Name|
|Prop.INN||Proposed International Nonproprietary Name (World Health Organization)|
|USAN||United States Adopted Name|
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.